進階篩選

Technical category
    • 多模肺癌臨床智慧決策分享輔助系統

      Precision Health Ecosystem FutureTech 多模肺癌臨床智慧決策分享輔助系統

      The proposed technologies apply deep learning methodsbig clinical data for lung cancer decision support. The system consists of: 1) CT radiogenomicspatho-genomics for automatic cancer detectionprediction of EGFR mutation 2) demographics to predict survival 3) genomics to predict cancer recurrencemetastasis,4) drug response inference for the best target therapy option. The modules are constructed on an AI-based Clinical Decision Support System (CDSS-SDM). The system is expected to provide physicianspatients with personalized medication recommendations.
    • 應用於精準醫學與智慧育種之基因體重組與品質評估整合平台

      FutureTech 應用於精準醫學與智慧育種之基因體重組與品質評估整合平台

      We are proposing a pipeline including de novo genome assemblywhole genome SNP array design to improve the practice in precision medicineprecision agriculture. We design GABOLA, a de novo genome assembly system, combining advantages in leading sequencing platform, to construct completeaccurate individual genomes. GABOLA can resolve large structural variants, fills the gap in human reference genome,avoid the bias from reference genome. We combine the knowledge of population geneticsfunctional information to design whole genome SNP array to aid future genomic study.
    • 基因體編輯技術在觀賞魚精準育種之應用

      FutureTech 基因體編輯技術在觀賞魚精準育種之應用

      CRISPR/Cas9 is the powerfulpopular genome editing technology which can recognize target gene by a single guide RNA with the advantages of precision, high efficiency, easy manipulation,low cost to be applied to promote the precision breeding of aquatic organisms. The potentials of genome editing in the precision breeding of ornamental fish are mainly focused on infertility control, alternation of colorshape, growth promotion, sex control, stress tolerance, virus resistance, etc.
    • A genomic marker guided roadmap to treat hepatocellular carcinoma

      Bio-tech & New Drugs FutureTech A genomic marker guided roadmap to treat hepatocellular carcinoma

      This is a method for identifying single nucleotide polymorphisms (GALNT14 genotypes) of a target nucleic acid for predicting whether a patient suffering from HCC will respond to combination chemotherapy. Accordingly, physicians can decide whether the HCC patients should receive chemotherapyTACE. This method could also predict prognosis in multiple gastrointestinal cancers.
    • 用於環境水質檢測與農作物之新穎重金屬生物感應器

      FutureTech 用於環境水質檢測與農作物之新穎重金屬生物感應器

      We developedoptimized a FRET-based genetically-encoded biosensor Met-lead with high sensitivity 10nM (0.2μg/dL, 2ppb) to fit the related regulations: the safety value of blood lead level for children 3μg/dLWHO-permitted level for tap water 10ppb. We further built a portable smart-phone device to measure Pb on-site. The practical applications of portable Met-lead can fulfill the needs from blood/urine Pb detection to drinking water/environmental irrigation water Pb monitoring, it will also help to build up a warning system to prevent further contamination from heavy metal Pb.
    • 遙控大腦

      FutureTech 遙控大腦

      ALTOMS (Altomated Laser TrackingOptogenetic Manipulation System) is a real-time computer vision object recognitionlaser tracker. It uses a missile-like image recognitiontracking technology,uses several lasers to accurately hit the tracked object. The laser itself does not have the function of controlling nerves, but when we express light-sensitive proteins on specific nerve cells, we can stimulateinhibit nerves through lasers of specific wavelengths, which will affect the behavioral outcome.
    • 非病毒磁性基因傳遞技術及其細胞治療應用

      FutureTech 非病毒磁性基因傳遞技術及其細胞治療應用

      Gene delivery technology is widely used in cell therapy, nucleic acid-based vaccines, protein production, gene therapy, etc. We have developed a non-viral gene delivery technology-MPGene, which has excellent gene delivery efficiency (50-80) for human mesenchymal stem cells,also has the characteristics of low production costhigh safety. In the future, MPGene has the potential to be used in important biomedical fields such as gene delivery reagents, major trauma cell therapy, malignant tumor treatmentcartilage cell therapy.
    • 人工智慧自動化優質細胞選取精進平台

      FutureTech 人工智慧自動化優質細胞選取精進平台

      Induced pluripotent stem cells are a promising new technology in translation medicine,AI technology is an automaticpowerful platform that can help identify cell images with unique characteristics, predictprovide information about cell types, differentiation stages, cell quality,normal Or disease-specific feature information. The combination of this induced pluripotent stem cell differentiation platformAI-based artificial intelligence image analysis technology will have great benefits for future cell product applications.
    • 子宮內膜癌安蓓甲基化基因檢測

      FutureTech 子宮內膜癌安蓓甲基化基因檢測

      The MPap DNA Methylation Test is an in vitro diagnostic reagent for endometrial cancer detection. For women atover 40 years of age with abnormal uterine bleeding, the methylation status of BHLHE22CDO1 genes from conventional Pap smear, can be used as an auxiliary diagnosis of endometrial cancer. The test result provides an important triage for further invasive endometrial biopsy, which will substantially reduce the need of invasive proceduresincrease the feasibility of endometrial cancer screening in high risk populations. This is a ground breaking test.
    • 適用於次世代定序識別基因變體之系統晶片

      FutureTech 適用於次世代定序識別基因變體之系統晶片

      This research presents a genetic variant discovery SoC for analyzing Next-generation sequencing data which is embedded with the processorconnected with some peripherals. With hardware-optimized algorithm sBWT, we greatly speed up the process of short reads mapping by k-ordered FM-indexsuffix grouping. After short reads mapping, we utilized de bruijn graph for sequence assembly to rebuild haplotypes,built haplotypes are compared to the reference genome to detect genome variations. The detected variations are written to files for further clinical diagnosisresearch analysis.
    • AI_Variant Prioritizer

      Precision Health Ecosystem FutureTech AI_Variant Prioritizer

      The interpretation of next generation sequencing is a big challenge. In order to improve the molecular diagnosis of the patient, we developed the AI_Variant prioritizer, a machine learning based variant prioterization system that can help to prioritize candidate variants for human disease. This module highlighted the possible disease causing variants to help clinician to increase the disease diagnostic yield and decrease the load of manpower.
    • 新冠肺炎相關研究小鼠小鼠模式之建構

      FutureTech 新冠肺炎相關研究小鼠小鼠模式之建構

      Our core generated several types of transgenic micea stable humanized ACE2 mice using a combi-CRISPR genetic engineering technique. We hope these mouse models can help to dissect COVID-19 pathogenic mechanismthe interaction(s) between spike proteinACE2 K353.
    • The establishment of National Biobank Consortium of Taiwan (NBCT)

      Precision Health Ecosystem FutureTech The establishment of National Biobank Consortium of Taiwan (NBCT)

      This project will establish a National biobank consortium of Taiwan through the fund support from the government. The National Health Research Institutes will establish a Central Office for the collaboration works, which includes collecting the number of samples of the human biological database in each biobank that agreed to join the Consortium. All Alliance need to follow the same SOP for the collection processthe quality of the biosample. Adequateconsistent clinical data will also be established under the Information Security Management Treaty. Since the contents of the biobanks from different institute are quite different, we will be able to quickly establish a largecomprehensive biobank network.In line with the need of biotechnologypharmaceutical industries.
    • 結合奈米技術與CRISPR/Cas9基因編輯應用於治療遺傳性疾病

      FutureTech 結合奈米技術與CRISPR/Cas9基因編輯應用於治療遺傳性疾病

      Supramolecular nanoparticles is a convenient, flexible,modular synthetic non-viral gene delivery vehicle for drug/gene delivery. The self-assembly of SMNPs is enabled upon mixing three different molecular building blocks, namely CD-PEI, Ad-PAMAM,Ad-PEG via Ad/CD motif-based molecular recognition. This allows modular control over the sizes, surface chemistry,payloads of SMNP vectors, thus holding promise for diverse therapeutic applications, especially for developing nanoparticle-based gene delivery platforms.
    • Precision blood test for detection of breast cancer

      Precision Health Ecosystem FutureTech Precision blood test for detection of breast cancer

      EPICAn is a novel technique that uses liquid biopsy for epigenetic analysis. Using methylation-specific PCR method to analyze specific gene methylation of cell-free DNA in plasma for early detection of breast cancer. The advantages of this technology are 1. High accuracy 2. Low false positive rate 3. Low-invasive 4. less limitation 5. Available for routine continuous detection 6. Monitoring cancer changes 7. Aided diagnosis 8. Automated process 9. Easy-to-operate 10. Rapid analysis. It is expected that EPICAn technique can increase the accuracy of early detection of breast canceraid clinicians diagnosis.
    • 粒線體功能分析平台與核苷酸研究之應用

      FutureTech 粒線體功能分析平台與核苷酸研究之應用

      In this research, we developed two platforms for analyzing mitochondrial stress. One is to use CRISPR/Cas9 editing to mark a variety of mitochondrial proteins in C. elegansmammalian cells for in vivo assessing mitochondrial functions. Another one is to establish a light-induced DNA damage specifically in mitochondria. In the meanwhile, we also developed a method to
    • Cisd2 activators: Novel therapeutics for non-alcoholic fatty liver diseases (NAFLD) and steatohepatitis (NASH)

      Precision Health Ecosystem FutureTech Cisd2 activators: Novel therapeutics for non-alcoholic fatty liver diseases (NAFLD) and steatohepatitis (NASH)

      Our previous studies suggested that increase Cisd2 levels may attenuate the pathogenesis of NAFLD/NASH. Accordingly, potent Cisd2 activators with the capacity to enhance Cisd2 levels were identified through the screening of skeletally diverse collections and structural optimization. So far BPRCD0001S0 is the most potent Cisd2 activator obtained, which has been studied extensively. Data obtained revealed that BPRCD0001S0 has no detectable toxicity in vivo, can activate Cisd2 in liver and ameliorate obese-related and fructose-induced NAFLD/NASH.
    • Small- and Wide-angle X-ray Scattering on Biological Structures

      FutureTech Small- and Wide-angle X-ray Scattering on Biological Structures

      (1) High flux mode for integrated measurements of SAXS/WAXS/UV-Vis-absorption/Refractive-index/Multi-angle-light-scattering (MALS) with an online high-performance liquid chromatography (HPLC) instrument, suitable for exploring biomacromolecular solution structures of a wide length scale and structural kinetics down to microsecond time scale. (2) Ultra SAXS (USAXS) mode for resolving hierarchical structures of bio-machinery assembly up to a few um length scale. (3) Anomalous SAXS mode for metal or mineral distributions (including calcium) in bio organelle or drug carriers. (4) Microbeam SAXS/WAXS mode for structural mapping of the textures or specific infected cells in natural/synthetic bio-tissues, organelles, or biomaterials.
    • 水溶液蛋白質與藥物微脂體檢測上的奇兵 - 生物結構小角度X光散射

      FutureTech 水溶液蛋白質與藥物微脂體檢測上的奇兵 - 生物結構小角度X光散射

      1.High flux mode for integrated measurements of SAXS/WAXS/UV-Vis-absorption/Refractive-index/Multi-angle-light-scattering (MALS) with an online high-performance liquid chromatography (HPLC) instrument, suitable for exploring biomacromolecular solution structures of a wide length scalestructural kinetics down to microsecond time scale. 2.Ultra SAXS (USAXS) mode for resolving hierarchical structures of bio-machinery assembly up to a few m length scale. 3.Anomalous SAXS mode for metalmineral distributions (including calcium) in bio organelledrug carriers.
  • 1